Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Mechanisms Of Orbitofrontal Stimulation in Depression

NCT: NCT07230990 · RECRUITING

NCT IDNCT07230990
StatusRECRUITING
Start Date2026-04-15
Completion2030-12

Brief Summary

The orbitofrontal cortex (OFC), a region involved in emotional regulation, decision making, and reward processing, is a key area linked to antidepressant response. This study tests whether noninvasive stimulation of the OFC using transcranial magnetic stimulation (TMS) can improve depressive symptoms. TMS uses magnetic fields generated by a coil placed next to the scalp to alter brain activity.

Frequently Asked Questions

What is Mechanisms Of Orbitofrontal Stimulation in Depression?

Mechanisms Of Orbitofrontal Stimulation in Depression is a clinical trial registered under NCT07230990. Current status: RECRUITING.

What is the status of NCT07230990?

The current status of NCT07230990 (Mechanisms Of Orbitofrontal Stimulation in Depression) is: RECRUITING.

When did Mechanisms Of Orbitofrontal Stimulation in Depression start?

Mechanisms Of Orbitofrontal Stimulation in Depression started on 2026-04-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.